Rather than broadly suppressing inflammation like NSAIDs do, peptides like BPC-157 and TB-500 appear to modulate the inflammatory response, supporting the beneficial early phase while promoting resolution and transition to the repair phase
Yang J, Shin KM, Abu Dabrh AM, et al
The arginate salt creates a buffering effect around the peptide chain
Furthermore, given that BPC 157 induces the same effect as therapy applied during reperfusion, or even later, in rats that had severe bowel obstruction, BPC 157 therapy could be a fundamental treatment involving the NO-system
Retrieved from Raghavan, R., Riley, A
This information does not claim that BPC-157 or TB-500 treats, cures, or prevents any disease or injury